The Food Shrinks are back with a spicy, heartfelt conversation about one of the most polarizing tools in the recovery world right now—GLP-1 medications (like Ozempic and Wegovy). In this episode, they tackle the growing buzz (and backlash) around these drugs in eating disorder and food addiction spaces. Are GLP-1s a betrayal of “real” recovery, or can they be a supportive tool for healing?

The hosts spill some behind-the-scenes tea, share their personal and clinical experiences, and ask hard questions: Who gets to decide what recovery looks like? Why is there so much shame around using medication? And what if we stopped gatekeeping tools that might help?

If you're curious about how GLP-1s fit into a trauma-informed, shame-free approach to food addiction recovery, this episode is for you.

In This Episode: • Why the GLP-1 debate is heating up in the recovery world • The team’s take on healing vs. weight loss goals • The difference between fear-based gatekeeping and client-centered care • What should recovery support look like when trying a new tool • The power of expanding your window of tolerance • Why we need to make room for nuance, autonomy, and compassion

Key Quote: "If a medication helps someone quiet the noise long enough to heal—why wouldn’t we support that?"

Resources & Support: 💻 Check out Sweet Sobriety to learn more about group programs and 1:1 coaching with Molly and Clarissa. 💻 Book a free Consultation with Molly Carmel 📧 Thinking about GLP-1s or bariatric surgery? Schedule a consultation with a coach who gets it.

If this episode resonated with you: ✔️ Subscribe ⭐ Rate & Review 📤 Share it with a friend who's curious about GLP-1s or exploring recovery options

The content of our show is educational only. It does not supplement or supersede your healthcare provider's professional relationship and direction. Always seek the advice of your physician or other qualified mental health providers with any questions you may have regarding a medical condition, substance use disorder, or mental health concern.